SIG
LEGN icon

Senator Investment Group’s Legend Biotech LEGN Stock Holding History

Senator Investment Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-155,000
Closed -$6.86M – 72
2024
Q2 		$6.86M Sell
155,000
-10,000
-6% -$461K 0.33% 51
2024
Q1 		$9.25M Buy
165,000
+50,000
+43% +$3.02M 0.42% 50
2023
Q4 		$6.92M Buy
115,000
+25,000
+28% +$1.58M 0.3% 57
2023
Q3 		$6.05M Hold
90,000
– – 0.34% 49
2023
Q2 		$6.21M Buy
+90,000
New +$5.88M 0.28% 48

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Senator Investment Group's LEGN Position: Q3 2024 in Review

Senator Investment Group sold out of Legend Biotech (LEGN) in Q3 2024, closing a stake of 155,000 shares — an estimated $6.86M sold.

Senator Investment Group first reported a position in LEGN in Q2 2023 and held it in 5 quarters. The position peaked at $9.25M in Q1 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q3 2024.

  • Senator Investment Group reported no remaining Legend Biotech position as of Q3 2024 after selling out during the quarter.
  • Senator Investment Group sold 155,000 Legend Biotech shares in Q3 2024, an estimated $6.86M.
  • Senator Investment Group first reported a position in Legend Biotech in Q2 2023 and held it in 5 quarters.
  • Senator Investment Group's Legend Biotech position peaked at $9.25M in Q1 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2024.

Based on Senator Investment Group's 13F filing for Q3 2024, filed 13 Nov 2024.